Biological clock genes are crucial and promising biomarkers for the therapeutic targets and prognostic assessment in gastric cancer

Abstract

Abstract Background: Gastric cancer is one of the major public health problems worldwide. Circadian rhythm disturbances driven by circadian clock genes play a role in the development of cancer. However, whether circadian clock genes can serve as potential therapeutic targets and prognostic biomarkers for gastric cancer remains elusive. Methods: In this study, we comprehensively analyzed the potential relationship between circadian clock genes and gastric cancer using online bioinformatics databases such as GEPIA, cBioPortal, STRING, GeneMANIA, Metascape, TIMER, TRRUST, and GEDS. Results: Biological clock genes are expressed differently in human tumors. Compared with normal tissues, only PER1, CLOCK and TIMELESS expression differences were statistically significant in gastric cancer (p<0.05). PER1(P=0.0169) and CLOCK (P=0.0414) were associated with gastric cancer pathological stage (p<0.05). Gastric cancer patients with high expression of PER1 (p=0.0028) and NR1D1 (p=0.016) had longer overall survival, while those with high expression of PER1 (p=0.042) and NR1D1 (p=0.016) had longer disease-free survival. The main function of the biological clock gene is related to the circadian rhythm and Melatonin metabolism and effects. CLOCK, NPAS2 are KAT2B were a key transcription factor for circadian clock genes. In addition, we also found important correlations between circadian clock genes and various immune cells in the gastric cancer microenvironment. Conclusions：This study may establish a new gastric cancer prognostic indicator based on the biological clock gene and develop new drugs for the treatment of gastric cancer using biological clock gene targets.